Curaleaf Holdings, Inc. has formally urged shareholders of Aurora Cannabis Inc. to accept its offer to acquire the company. In a press release dated September 15, 2026, Curaleaf announced that its Chairman and CEO, Boris Jordan, sent a letter to Aurora shareholders encouraging them to tender their shares.
The offer, which was first announced on August 18, 2026, is valued at approximately US$4.00 per Aurora share. This price represents a 45% premium over the 30-day volume weighted average price of Aurora’s common shares as of August 10, 2026. Under the terms of the proposal, Aurora shareholders would receive 0.3463 Curaleaf shares and US$0.75 in cash for every share of Aurora they own.
Curaleaf stated that a combined entity would create the world's largest and most diversified cannabis company. The company projected that the combined business would generate more than US$1.5 billion in last twelve-month revenue and nearly US$350 million in adjusted EBITDA. Additionally, Curaleaf estimated that the merger would result in at least US$40 million of annual cost synergies.
Curaleaf highlighted that Aurora’s standalone business has been shrinking, with net revenue and adjusted EBITDA declining 14% and 78%, respectively, over the four quarters ended June 30, 2026. The company also noted that Aurora has raised more than US$400 million through dilutive equity issuances since 2021.
Aurora shareholders are advised to tender their shares before December 1, 2026. Curaleaf has scheduled a live shareholder Q&A session with Chairman and CEO Boris Jordan on Thursday, September 17, 2026, at 10:30 a.m. ET. Interested parties can register for the webcast at grow.curaleaf.com.
